Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | Patent Application Number 16024340
16024340
Not Appealed
Patent NumberUS 10308714 B2
Publication NumberUS 20180319887 A1
Filled DateJun 29, 2018
Priority DateMay 15, 2012
Inventor/ApplicantsJohn P. Cogswell
Xi-Tao Wang
Jon M. Wigginton
Maria Jure-Kunkel
Stacie M. Goldberg
Ashok K. Gupta
Xi-Tao Wang
Jon M. Wigginton
Maria Jure-Kunkel
Stacie M. Goldberg
Ashok K. Gupta
ExaminesOUSPENSKI, ILIA I
Art Unit1644
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.